Sequential Compression Device in Distributive Peripheral Edema and Hemodynamic Stability Among Patients in Critical Care Units
SCD
Effectiveness of Sequential Compression Device in Distributive Peripheral Edema and Hemodynamic Stability Among Patients in Critical Care Units
1 other identifier
interventional
56
1 country
1
Brief Summary
Objectives of The Study:
- 1.Assess the effectiveness of sequential compression device on distributive peripheral edema and hemodynamic stability for patients in critical care units.
- 2.Find out relationships between the effectiveness of sequential compression device, range of motion, and synergic effectiveness of both interventions with patients' demographic characteristics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 12, 2025
CompletedFirst Posted
Study publicly available on registry
December 26, 2025
CompletedStudy Start
First participant enrolled
December 28, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 20, 2026
CompletedMay 22, 2026
May 1, 2026
3 months
December 12, 2025
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Peripheral edema
Firstly, the edema of lower extremities was measured for all patients in critical care units through pitting edema scale before selecting the participants, then the patients selected for the current study had pitting edema scale \>+1. Also, leg circumference had measured by using tape measurement.
The degree of edema will be measured before applying interventions and after 5 consecutive days if study
Hemodynamic Stability
Hemodynamic parameters were also assessed before interventions. The Hemodynamic parameters that include the heart rate, blood pressure, respiratory rate, urine output and saturation of oxygen was measured by observation of the reading on the monitoring device that was used in critical care units and attached to the patient, the reading was documented by the researcher.
Hemodynamic parameters will be measured before applying interventions and after 5 consecutive days if study
Study Arms (2)
Sequential Compression Device group
ACTIVE COMPARATORSequential Compression Device (SCD) participants group involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.
control group
NO INTERVENTIONcontrol group will receives standard care
Interventions
Sequential Compression Device (SCD) protocol involves a pump linked to calf and thigh braces with individual tubes, applying moderate pressure of approximately 60mmHg through a graduated air chamber in a sequential cycle across four compartments. The inflation lasts for 12 seconds followed by a 48-second deflation, with sessions lasting 2 hours daily for 5 consecutive days.
Eligibility Criteria
You may qualify if:
- Adult patients who were hospitalized in critical care units.
- Subjects over the age of 18 years.
- Presence of peripheral edema (pitting edema ≥1+ in lower extremities).
- Patients how are hemodynamically stable.
- Patients how are able to tolerate positioning for interventions.
You may not qualify if:
- Patients with lymphedema.
- Patients with chronic kidney disease.
- patients with presence of deep vein thrombosis, severe peripheral arterial disease, or phlebitis.
- patients with open wounds, ulcers, or skin infections on lower limbs.
- patients with fractures, orthopedic surgery, or joint immobility in lower extremities.
- patients with severe cardiac failure or pulmonary edema.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kerbala health department
Karbala, Center, 56001, Iraq
Study Officials
- PRINCIPAL INVESTIGATOR
Hussein H Jawad MGS study principal investigator
Kerbala health department
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- non
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Masters graduate student
Study Record Dates
First Submitted
December 12, 2025
First Posted
December 26, 2025
Study Start
December 28, 2025
Primary Completion
March 15, 2026
Study Completion
June 20, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share